Galmed Pharmaceuticals (GLMD) Q1 2023 Earnings

1JunConfirmed
Nov 22
Jan 23
Q4 2022
Q1 2023
-1.5
-1.03
-0.57
-0.1

Details

Expected EPS
-1.5
Actual EPS
-1.09
Surprise EPS
0.41
Surprise Percent
+27.33%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -1.09 per share for Q1 2023.

0 Comments

Share your thoughts